4536:TYO
Santen Pharmaceutical Co Ltd
Â¥1,726.50
arrow_downward
-0.66%(-11.50) 1D
Oct 19, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4536...
Open
Â¥1,754
High
Â¥1,758
Low
Â¥1,723
Mkt. cap
556.48B
Avg. vol.
1.32M
Volume
629.00K
Dividend
2.20%
Quarterly dividend
Â¥10
Ex-dividend date
Sep 29, 2026
P/E ratio
14.41
52-wk high
Â¥2,254
52-wk low
Â¥1,458
EPS
Â¥120
Shares outstanding
407.09M
No. of employees
4K
Open
Â¥1,754
High
Â¥1,758
Low
Â¥1,723
Mkt. cap
556.48B
Avg. vol.
1.32M
Volume
629.00K
Dividend
2.20%
Quarterly dividend
Â¥10
Ex-dividend date
Sep 29, 2026
P/E ratio
14.41
52-wk high
Â¥2,254
52-wk low
Â¥1,458
EPS
Â¥120
Shares outstanding
407.09M
No. of employees
4K
News stories
From web sources and news partners
HDFC Sky
·
35 minutes ago
Nasdaq Jumps 259 Points to 26,399 as Intel Surges 5.5% and AI Stocks Rebound After Brutal Selloff
TipRanks
·
28 minutes ago
Dow Jones Steady as AI Stocks Rebound from Selloff
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.08% Lower
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3.97K
Founded1890
HeadquartersOsaka, Kansai, Japan
SectorPharmaceutical industry
Websitesanten.com